Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Soleno Therapeutics Inc shares valued at $110,696,581 were purchased by Abingworth Bioventures VII LP on Aug 11 ’25. At $82.15 per share, Abingworth Bioventures VII LP acquired 1,347,522 shares.
Also, Hirano Patricia C sold 3,830 shares, netting a total of over 316,971 in proceeds. Following the sale of shares at $82.76 each, the insider now holds 13,206 shares.
Before that, PATRICIA HIRANO had added 3,830 shares to its account. In a trade valued at $316,971, the Officer bought Soleno Therapeutics Inc shares for $82.76 each.
As published in their initiating research note from Wells Fargo on August 20, 2025, Soleno Therapeutics Inc [SLNO] has been an Overweight and the price target has been revised to $123. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. Earlier on December 02, 2024, Stifel resumed its rating. Their recommendation was “a Buy” for SLNO stock.
Analyzing SLNO Stock Performance
On last trading session, Soleno Therapeutics Inc [NASDAQ: SLNO] rose 3.19% to $68.94. The stock’s lowest price that day was $66.885, but it reached a high of $69.05 in the same session. During the last five days, there has been a drop of approximately -15.04%. Over the course of the year, Soleno Therapeutics Inc shares have jumped approximately 42.32%. Shares of the company reached a 52-week high of $90.32 on 07/09/25 and a 52-week low of $41.50 on 01/15/25.
Support And Resistance Levels for Soleno Therapeutics Inc (SLNO)
According to the 24-hour chart, there is a support level at 67.53, which, if violated, would cause prices to drop to 66.12. In the upper region, resistance lies at 69.71. The next price resistance is at 70.47. RSI (Relative Strength Index) is 32.07 on the 14-day chart, showing neutral technical sentiment.
Is Soleno Therapeutics Inc subject to short interest?
Stocks of Soleno Therapeutics Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.69 million shares to 6.04 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 5.35 million shares. A jump of 11.37% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.4 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.4.
Which companies own the most shares of Soleno Therapeutics Inc (SLNO)?
In terms of Soleno Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 105 in the next 12 months, up nearly 57.16% from the previous closing price of $66.81. Analysts anticipate Soleno Therapeutics Inc stock to reach 121 by 2025, with the lowest price target being 81. In spite of this, 3 analysts ranked Soleno Therapeutics Inc stock as Buy at the end of 2025. On December 02, 2024, Robert W. Baird assigned a price target of “an Outperform” to the stock and reiterated coverage with a $72.
